Literature DB >> 30010060

Interleukin-4 and STAT6 promoter polymorphisms but not interleukin-10 or 13 are essential for schistosomiasis and associated disease burden among Nigerian children.

Samuel A Adedokun1, Brooke N Seamans2, Natalya T Cox3, Gialeigh Liou4, Akeem A Akindele5, Yi Li6, Olusola Ojurongbe7, Bolaji N Thomas8.   

Abstract

Schistosomiasis is endemic in many parts of rural Africa, with previous reports showing interleukin-13 polymorphisms as drivers of infectivity and disease severity in West Africa while IL-13/IL-4 polymorphisms contributes to patterns of reinfection in East Africa. We have shown that there is a genetic delineation in susceptibility to and severity of infectious diseases in Africa, in addition to sub-continental differences in disease pattern. Therefore, which immunoregulatory biomarkers are essential in driving S. haematobium infection or regulate disease burden among Nigerian school children? One hundred and thirty one age and sex-matched schistosome-infected children and 275 uninfected controls, of same ethnicity, recruited from southwestern Nigeria, were screened for variability of cytokine genes, IL-10 (rs1800872), IL-13 (rs7719175), IL-4 (rs2243250) and STAT6 (rs3024974), utilizing a polymerase chain reaction-restriction fragment length polymorphism assay. We found no difference in genotypic or allelic frequencies of IL-10 and IL-13 promoter polymorphisms alone or in association with disease. Contrariwise, we report significant differences in the frequencies of IL-4 and STAT6 variants between groups. For IL-4, the rs2243250 T/T variant was significantly different for genotypes (71.6% versus 51.2%; p < .0004) and alleles (82.6% versus 71.1%; p < .001) between disease and control groups respectively. For STAT6 (rs3024974), the frequencies of genotypes C/C and C/T are 75.4% and 24.6%, both showing an association with disease; none of the infected subjects had the T/T variant. Despite minor differences in disease covariates, we found no association between IL-4 and STAT6 variants with age, gender or anemia. However, mean egg count (indicative of disease burden), was regulated based on IL-4 variants, with highest burden in infected subjects with rs2243250 T/T variant (mean egg count: 207.5 eggs/10 ml of urine) versus rs2243250 C/T heterozygotes (mean egg count: 84.3 eggs/10 ml of urine) versus rs2243250 C/C (mean egg count: 127.9 eggs/10 ml of urine). Comparing rs2243250 C/T versus rs2243250 T/T (p < .008) or rs2243250 C/C + C/T versus rs2243250 T/T (p < .016) reveals an association with disease burden. We conclude that the IL-4 promoter gene is a susceptibility factor for schistosomiasis, and essential to regulate disease burden, with worse disease among carriers of the rs2243250 T/T variant. The absence of the STAT6, rs3024974T/T variant among infected subjects reveal the necessity of the STAT6 promoter gene in driving susceptibility to schistosomiasis in Nigeria.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Africa; Egg burden; IL-10; IL-13; Interleukin-4; STAT6; Schistosomiasis

Mesh:

Substances:

Year:  2018        PMID: 30010060     DOI: 10.1016/j.meegid.2018.07.012

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  6 in total

1.  Interleukin-4 Signaling Plays a Major Role in Urogenital Schistosomiasis-Associated Bladder Pathogenesis.

Authors:  Evaristus C Mbanefo; Chi-Ling Fu; Christina P Ho; Loc Le; Kenji Ishida; Olfat Hammam; Michael H Hsieh
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

2.  Frequency distribution of cytokine and associated transcription factor single nucleotide polymorphisms in Zimbabweans: Impact on schistosome infection and cytokine levels.

Authors:  Andrew John Hanton; Fiona Scott; Katharina Stenzel; Norman Nausch; Grace Zdesenko; Takafira Mduluza; Francisca Mutapi
Journal:  PLoS Negl Trop Dis       Date:  2022-06-27

Review 3.  The Genetics of Human Schistosomiasis Infection Intensity and Liver Disease: A Review.

Authors:  Estelle M Mewamba; Oscar A Nyangiri; Harry A Noyes; Moses Egesa; Enock Matovu; Gustave Simo
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

4.  Candidate gene family-based and case-control studies of susceptibility to high Schistosoma mansoni worm burden in African children: a protocol.

Authors:  Oscar A Nyangiri; Sokouri A Edwige; Mathurin Koffi; Estelle Mewamba; Gustave Simo; Joyce Namulondo; Julius Mulindwa; Jacent Nassuuna; Alison Elliott; Kévin Karume; Dieudonne Mumba; P L A M Corstjens; M Casacuberta-Partal; G J van Dam; Bruno Bucheton; Harry Noyes; Enock Matovu
Journal:  AAS Open Res       Date:  2021-12-15

5.  C/EBP Homologous Protein (CHOP) Activates Macrophages and Promotes Liver Fibrosis in Schistosoma japonicum-Infected Mice.

Authors:  Mengyun Duan; Yuan Yang; Shuang Peng; Xiaoqin Liu; Jixin Zhong; Yurong Guo; Min Lu; Hao Nie; Boxu Ren; Xiangzhi Zhang; Lian Liu
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

6.  CD209 and Not CD28 or STAT6 Polymorphism Mediates Clinical Malaria and Parasitemia among Children from Nigeria.

Authors:  Olanrewaju B Morenikeji; Jessica L Metelski; Megan E Hawkes; Anna L Capria; Brooke N Seamans; Catherine O Falade; Olusola Ojurongbe; Bolaji N Thomas
Journal:  Microorganisms       Date:  2020-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.